INSL3 and neoplasm: INSL3 was also demonstrated to promote early tumor cell invasiveness in human thyroid carcinoma cells by enhancing their metabolic activity and elastin-degrading potential via increasing the production of the lysosomal enzymes cathepsin-L and cathepsin-D [36].